Christiaan De Wilde
![]() |
Christiaan De Wilde is a Belgian businessman, and he is at present the chief executive officer of the biotech company Fujirebio Europe NV, a member of Japan-based Fujirebio.
Education
Christiaan De Wilde in Accountancy at the Hogeschool Gent (BME) (Ghent) and obtained a degree in taxation and a master's degree in industrial entrepreneurship, both at EHSAL (Brussels).
Career
In October 1988, he started his career at Johnson & Johnson, where he would stay for 17 years. From June 2000 until May 2005, he was finance and logistics director for the Benelux and a member of the board of Johnson & Johnson Medical BV (Netherlands). Until August 2006, he was finance and logistics director and a member of the board of Janssen-Cilag Belgium NV.
On 1 September 2006, he was appointed chief financial and administration officer of Innogenetics (today Fujirebio Europe) and on 15 October 2007, he became executive officer and a member of the board.
Sources
- Christiaan De Wilde
- Innogenetics appoints Christiaan De Wilde as Chief Financial Officer
- Innogenetics names Christiaan De Wilde as CFO from Sept 1
- Articles with short description
- Short description is different from Wikidata
- BLP articles lacking sources from February 2023
- All BLP articles lacking sources
- Use dmy dates from April 2021
- Living people
- Flemish businesspeople
- Year of birth missing (living people)
- Belgian chief executives
- Belgian accountants
- 20th-century Belgian businesspeople
- 21st-century Belgian businesspeople
- All stub articles
- Belgian business biography stubs